Bioventus Inc. (BVS) vs CONMED Corporation (CNMD)
Bioventus Inc. and CONMED Corporation are both Medical Devices companies. CONMED Corporation is the larger, with a market value of $1.4B against $1.1B — 1.2× the size. Bioventus Inc. trades at the lower P/E: 17.0× against 24.5×. CONMED Corporation grew revenue faster over the last twelve months: 3.42% against 3.14%. Bioventus Inc. has the higher net margin (9.36% vs 4.12%) and the higher return on invested capital (7.34% vs 3.75%). Across the 22 metrics below, Bioventus Inc. leads on 16 and CONMED Corporation on 6.
Valuation
Profitability
| Metric | BVS | CNMD | Medical Devices median |
|---|---|---|---|
| Gross margin | 68.65% | 55.79% | 56.01% |
| Operating margin | 10.02% | 8.04% | (15.03%) |
| Net margin | 9.36% | 4.12% | (20.40%) |
| Free cash flow margin | 16.20% | 9.80% | (7.24%) |
| Return on equity | 22.75% | 5.53% | (15.32%) |
| Return on assets | 7.89% | 2.44% | (19.72%) |
| Return on invested capital | 7.34% | 3.75% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack